欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
CCT244747_1404095-34-6_产品详情
1404095-34-6
  • names:

    CCT244747

  • CAS号:

    1404095-34-6

    MDL Number:
  • MF(分子式): C20H24N8O2 MW(分子量): 408.46
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
CCT244747
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
YZM002339-5mg 5mg >99.0% ¥ 2025.00 ¥ 2025.00 2-3天
- +
¥ 0.00
YZM002339-2mg 2mg >99.0% ¥ 1170.00 ¥ 1170.00 2-3天
- +
¥ 0.00
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 1404095-34-6
Inchi
InchiKey
分子式 Formula C20H24N8O2
分子量 Molecular Weight 408.46
溶解度Solubility 生物体外In Vitro:DMSO溶解度100 mg/mL(244.82 mM;Need ultrasonic)
性状
储藏条件 Storage conditions 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月
CCT244747(CAS:1404095-34-6)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 CCT244747 是一种有效的,可口服的,高度选择性的CHK1抑制剂,IC50值为 7.7 nM;CCT244747 可废除 G2 检查点,IC50值为 29 nM
IntroductionCCT244747 is a potent, orally bioavailable and highly selectiveCHK1inhibitor, with anIC50of 7.7 nM; CCT244747 also abrogates G2 checkpoint with anIC50of 29 nM.
Application1
Application2
Application3
CCT244747 是一种有效的,可口服的,高度选择性的CHK1抑制剂,IC50值为 7.7 nM;CCT244747 可废除 G2 检查点,IC50值为 29 nM。CCT244747 is a potent, orally bioavailable and highly selectiveCHK1inhibitor, with anIC50of 7.7 nM; CCT244747 also abrogates G2 checkpoint with anIC50of 29 nM.
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Lainchbury M, et al. Discovery of 3-alkoxyamino-5-(pyridin-2-ylamino)pyrazine-2-carbonitriles as selective, orally bioavailable CHK1 inhibitors. J Med Chem. 2012 Nov 26;55(22):10229-40.
【2】.Walton MI, et al. CCT244747 is a novel potent and selective CHK1 inhibitor with oral efficacy alone and in combination with genotoxic anticancer drugs. Clin Cancer Res. 2012 Oct 15;18(20):5650-61.
【3】.Patel R, et al. An orally bioavailable Chk1 inhibitor, CCT244747, sensitizes bladder and head and neck cancer cell lines to radiation. Radiother Oncol. 2017 Mar;122(3):470-475.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents